CCO - CDK4/6 inhibitors in early-stage HR+/HER2- breast cancer: Individualizing therapeutic decisions to improve patient outcomes
Industry Satellite Symposia
Calendar Export
Summary, final thoughts and live Q&A
(ID 339)
Lecture Time
19:45 - 19:55
Speakers
A. Speakers
(, Switzerland)
Session Name
CCO - CDK4/6 inhibitors in early-stage HR+/HER2- breast cancer: Individualizing therapeutic decisions to improve patient outcomes
Room
Channel 1
Date
Wed, 05.05.2021
Time
19:00 - 20:00